{
  "id": 19569453,
  "title": "Experts urge caution over drug company campaigns to destigmatize obesity",
  "url": "https://urgent.news/2026/11/11/experts-urge-caution-over-drug-company-campaigns-to-destigmatize",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-11T23:30:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-experts-urge-caution-drug-company.html"
  },
  "original_language": "en",
  "account": "Experts are cautioning against pharmaceutical company campaigns aimed at destigmatizing obesity, according to a recent article in The BMJ. While such campaigns are well-intentioned, there is a risk that these companies, which profit from obesity treatments, may influence public discourse and national policy. Eli Lilly's \"Obesity Is a Disease\" campaign in the UK serves as a prime example. Although the campaign accurately conveys messages about the stigma associated with obesity, it is run by a pharmaceutical company whose drug tirzepatide is a key treatment for obesity. The authors argue that the campaign's focus on treatment rather than social and environmental factors may inadvertently shift responsibility and resources away from addressing the root causes of obesity, such as urban planning, food environments, poverty, and marketing. The convergence of scientifically defensible arguments and commercial interests makes it challenging to criticize such campaigns, which may unintentionally endorse a treatment-first approach to obesity. Regulators should carefully examine these campaigns and determine the appropriate limits of codes of conduct, considering both the destigmatization benefits and the potential commercial influences.",
  "summary": "We should be wary of campaigns by pharmaceutical companies to destigmatize obesity, say experts in The BMJ. Michael Viggars and colleagues argue that, while destigmatizing obesity is the right thing to do, there is a risk that companies profiting from obesity treatment come to influence public conversation and national policy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}